Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group - Concepedia

Concepedia

Publication | Open Access

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

DOI Full Paper Access

182

Citations

50

References

2009

Year

David S. Miller, John A. Blessing, Carolyn Krasner, Robert S. Mannel, Parviz Hanjani, Michael L. Pearl, Steven Waggoner, Cecelia H. Boardman

Journal of Clinical Oncology

Abstract

Pemetrexed has sufficient activity in the treatment of recurrent platinum-resistant ovarian cancer at the dose and schedule tested to warrant further investigation.

References

	Year	Citations

Page 1